# Relmada Therapeutics, Inc.: Form 8-K, filed Sep 17, 2025

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2025-09-17
- Accepted by EDGAR: Sep 17, 2025, 07:30 ET
- Period: 2025-09-17
- Accession: 0001213900-25-088360
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390025088360/ea0257659-8k_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390025088360/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390025088360/ea0257659-8k_relmada.htm

Filed Sep 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-088360. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.